Replies to post #4834 on Bausch Health Companies Inc (BHC)

[conix]

Bausch Health sees FY20 revenue to exceed higher end of previous guidance

Jan. 12, 2021 4:28 PM ET

Bausch Health Companies Inc. (BHC)

Bausch Health (NYSE:BHC) expects its Q4 revenue to be greater than $2.20B vs. consensus of $2.12B.

FY20 to exceed the high end of its latest revenue guidance range of $7.80 – $8B vs. consensus of $7.93B

The company expect a strong finish to the year with regard to Adjusted EBITDA (non-GAAP)," said Joseph C. Papa, chairman and CEO.
"We look forward to releasing our full financial results for the fourth quarter and full year of 2020 next month."

The company expects to exceed $1B in cash generated from operations for FY20 due to strong cash flow in Q4.

In total, the Company repaid ~$900M of debt in 2020 from cash generated from operations and more efficient cash management, and has no debt maturities or mandatory amortization payments until 2024.